Study finds pre-hospital administration of bivalirudin substantially improves outcomes compared to heparin in heart attack patients

(Cardiovascular Research Foundation) According to a new study, administering the blood thinner bivalirudin to patients experiencing an ST-elevation myocardial infarction (STEMI, the most serious form of a heart attack) in a pre-hospital setting can reduce the risk of death and major bleeding complications compared to heparin with optional use of glycoprotein IIb/IIIa inhibitors.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news